Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Market Cap ($796.06 Million)
Market Cap & Net Worth: Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408)
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A market cap. Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (SHE:301408) has a market capitalization of $796.06 Million (CN¥5.44 Billion) as of November 1, 2026. Listed on the SHE stock exchange, this China-based company holds position #9537 globally and #2332 in its home market, demonstrating a 1.64% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's stock price CN¥13.60 by its total outstanding shares 400010000 (400.01 Million). Also see cash efficiency ratio of Anhui Huaren Health Pharmaceutical Co. L for how efficiently the company converts equity into cash flow.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Market Cap History (2023–2026)
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A market cap history from 2023 to 2026. Data shows change from $925.22 Million to $796.06 Million (-15.37% CAGR). Check Anhui Huaren Health Pharmaceutical Co. L (301408) stock price for real-time trading data and today's change.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 301408 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.20x
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's market cap is 0.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.68x
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's market cap is 5.68 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $925.22 Million | $3.80 Billion | $114.67 Million | 0.24x | 8.07x |
| 2024 | $645.63 Million | $4.53 Billion | $137.70 Million | 0.14x | 4.69x |
| 2025 | $1.09 Billion | $5.49 Billion | $191.35 Million | 0.20x | 5.68x |
Competitor Companies of 301408 by Market Capitalization
Companies near Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A in the global market cap rankings as of November 1, 2026. Also see Anhui Huaren Health Pharmaceutical Co. L asset portfolio for a full breakdown of the balance sheet.
Key companies related to Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1867 globally with a market cap of $12.04 Billion USD ( €10.30 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2108 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2442 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #3350 globally with a market cap of $5.22 Billion USD ( R$26.61 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1867 | JD HEALTH INTL LTD | F:8ZN | $12.04 Billion | €4.30 |
| #2108 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2442 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #3350 | Raia Drogasil S.A | SA:RADL3 | $5.22 Billion | R$15.22 |
Market Capitalization of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2023–2026)
Market capitalization of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2023 to today. Between 2023 and today, Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's market cap moved from $925.22 Million to $ 796.06 Million, with a yearly change of -15.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥796.06 Million | -26.72% |
| 2025 | CN¥1.09 Billion | +68.27% |
| 2024 | CN¥645.63 Million | -30.22% |
| 2023 | CN¥925.22 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 1st, 2026 the market cap of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $796.06 Million USD |
| MoneyControl | $796.06 Million USD |
| MarketWatch | $796.06 Million USD |
| marketcap.company | $796.06 Million USD |
| Reuters | $796.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, heat-clearing, respiratory system, and gynecology, as well as provides vitamins and minerals, and detoxifying products. In addition, it provides supplements, and nutrition and health products. Anhui Huaren Health Pharmaceutical Co., Ltd. was founded in … Read more